Targeted, heterozygous disruption of exon 1 of the Gnas gene (GnasE1−/+) provided a mouse model of AHO, which recapitulated some of the features of the human disease [10], [23], [24]. This evidence concerns the gene GNAS and pseudohypoparathyroidism type 1A.